LIMES Schlosskliniken (LIK) Stock Overview
Operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, and Liechtenstein. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for LIK from our risk checks.
LIK Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
LIMES Schlosskliniken AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €366.00 |
| 52 Week High | €408.00 |
| 52 Week Low | €250.00 |
| Beta | 0.59 |
| 1 Month Change | -7.58% |
| 3 Month Change | -4.19% |
| 1 Year Change | -0.54% |
| 3 Year Change | 39.69% |
| 5 Year Change | 266.00% |
| Change since IPO | 251.92% |
Recent News & Updates
We Like These Underlying Return On Capital Trends At LIMES Schlosskliniken (ETR:LIK)
Sep 02
Earnings Not Telling The Story For LIMES Schlosskliniken AG (ETR:LIK) After Shares Rise 29%
Jun 12Recent updates
We Like These Underlying Return On Capital Trends At LIMES Schlosskliniken (ETR:LIK)
Sep 02Earnings Not Telling The Story For LIMES Schlosskliniken AG (ETR:LIK) After Shares Rise 29%
Jun 12LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price
Feb 22These 4 Measures Indicate That LIMES Schlosskliniken (ETR:LIK) Is Using Debt Reasonably Well
Dec 18LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit
May 21Why We Like The Returns At LIMES Schlosskliniken (ETR:LIK)
Apr 12Returns on Capital Paint A Bright Future For LIMES Schlosskliniken (ETR:LIK)
Sep 07Under The Bonnet, LIMES Schlosskliniken's (ETR:LIK) Returns Look Impressive
Dec 21LIMES Schlosskliniken AG's (ETR:LIK) Shares May Have Run Too Fast Too Soon
Sep 24LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations
May 23LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price
Mar 24Here's Why LIMES Schlosskliniken (ETR:LIK) Can Manage Its Debt Responsibly
Nov 16Would LIMES Schlosskliniken (ETR:LIK) Be Better Off With Less Debt?
May 17Shareholder Returns
| LIK | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.5% | 2.5% | 2.7% |
| 1Y | -0.5% | 30.1% | 14.5% |
Return vs Industry: LIK underperformed the German Healthcare industry which returned 30.1% over the past year.
Return vs Market: LIK underperformed the German Market which returned 14.5% over the past year.
Price Volatility
| LIK volatility | |
|---|---|
| LIK Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 12.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: LIK has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: LIK's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 237 | Gert Frank | www.limes-schlosskliniken.de |
LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, and Liechtenstein. It focuses on the treatment of stress-related illnesses; and mental and psychological disorders, such as depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, personality disorder, chronic pain, psychoses, obsessive compulsive disorder, sleep disorder, somatoform disorder, and sports psychiatry. The company was formerly known as GMF Capital AG and changed its name to LIMES Schlosskliniken AG in December 2005.
LIMES Schlosskliniken AG Fundamentals Summary
| LIK fundamental statistics | |
|---|---|
| Market cap | €109.80m |
| Earnings (TTM) | €4.60m |
| Revenue (TTM) | €41.87m |
Is LIK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LIK income statement (TTM) | |
|---|---|
| Revenue | €41.87m |
| Cost of Revenue | €22.83m |
| Gross Profit | €19.04m |
| Other Expenses | €14.44m |
| Earnings | €4.60m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.32 |
| Gross Margin | 45.48% |
| Net Profit Margin | 10.98% |
| Debt/Equity Ratio | 52.2% |
How did LIK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/05 02:29 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LIMES Schlosskliniken AG is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Norbert Kalliwoda | Dr. Kalliwoda Research |